Turkish drugmaker Bilim Ilac may have found a private-equity investor. Reuters reports the pharma company is in talks to sell a stake to Actera, a Turkish-focused firm with a $500 million-plus fund ...

London-based private equity firm CVC Capital Partners, European buyout firm Cinven and London-based Advent Venture Partners are all in the running for a stake in Turkish drug maker Bilim Ilac, Reuters ...

ISTANBUL, Aug 11 (Reuters) - Turkish drugmaker Bilim Ilac is in talks to sell a stake to private equity firm Actera and discussions are expected to conclude next month, a Bilim Ilac official told ...

Bilim Ilac, which is the third biggest Turkish drugmaker by revenue and box sales, was not immediately available to comment. It had a 5.1 percent market share in 2010, according to the company's ...

ISTANBUL, April 8 (Reuters) - European buyout firms Cinven, CVC and Advent International are among potential buyers of a stake in Bilim Ilac in a sale that may value the Turkish drugmaker at about $1 ...